Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Una discusión entre la Dra. Leticia M. Pérez Saleme y el Dr. Luis Enrique Soto-Ramírez: antenimiento de la atención del VIH durante la pandemia de COVID-19 en México

Vea esta discusión de profesores expertos sobre la colisión de VIH y COVID-19 en México, incluyendo, el impact del VIH en la prevalencia y la gravedad de la enfermedad de COVID-19, el impacto de la COVID-19 en la atención al VIH en México, y las estrategias e intervenciones para mitigar el impacto de la COVID-19 en la atención del VIH.
Leticia M. Pérez Saleme, MD
Luis E. Soto-Ramirez, MD
Released: December 22, 2020

Information on this Educational Activity

Faculty

Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

El Dr. Luis Enrique Soto-Ramírez ha informado que cobró honorarios por asesoramiento de Gilead Sciences, GlaxoSmithKline, Merck y ViiV Healthcare, y honorarios por servicios no relacionados con CME/CE de Gilead Sciences, Janssen y Merck.
Leticia M. Pérez Saleme, MD

President
CISIDAT Consorcio de Investigación en VIHISIDA y Tuberculosis A.C.
Infectious Diseases Consultant
Cuernavaca, Mexico

La Dra. Leticia M. Pérez Saleme ha informado que cobró honorarios por asesoramiento de Gilead Sciences y Merck, y honorarios por servicios no relacionados con CME/CE de BD, Gilead Sciences, Janssen, Sandoz y Siegfried.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer M. Blanchette, PhD, no tiene conflictos de intereses relevantes que reportar
Edward King, MA

Executive Vice President

Edward King, MA, no tiene conflictos de intereses relevantes que reportar.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, no tiene conflictos de intereses relevantes que reportar.
Tiffany Hensley-McBain, PhD

Scientific Director

Tiffany Hensley-McBain, PhD, no tiene conflictos de intereses relevantes que reportar.

Program Medium

This program has been made available online.

Related Content

Clinical Care Options (CCO) expert analysis of new HIV data from IDWeek 2021, provided by expert HIV faculty

Eric S. Daar, MD Released: October 21, 2021

Slides from CCO: ART in Pregnancy: guideline recommendations and supporting data, pharmacokinetic considerations, and drug-drug interactions

person default Milena Murray, PharmD, MSc, BCIDP, AAHIVP Jonah Musa, MBBS, MSCI, PhD Released: October 20, 2021

Expert selections of important HIV data from IDWeek 2021, including current and investigational ART, HIV PrEP, and metabolic outcomes of ART.

Eric S. Daar, MD Darcy Wooten, MD Released: October 19, 2021

Concise Clinical Care Options (CCO) presentation by Nicholas Chamberlain, MD, on investigational HIV PrEP strategies in various stages of development

Nicholas Chamberlain, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: October 15, 2021 Expired: October 14, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue